Met Life Investment Management, LLC Humacyte, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 79,316 shares of HUMA stock, worth $149,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,316
Previous 51,442
54.19%
Holding current value
$149,114
Previous $87,000
89.66%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HUMA
# of Institutions
170Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$13.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$8.26 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$6.45 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$5.54 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $194M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...